4.7 Review

Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis

Luca Massimino et al.

Summary: This study analyzes the transcriptomics and multi-omics data of EoE, revealing the molecular features, microbiota dysbiosis, and antigen-mediated response of the disease. It suggests that advanced bioinformatics and omics-based approaches can help in the management and treatment of EoE.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Review Gastroenterology & Hepatology

Factors affecting the quality of bowel preparation for colonoscopy in hard-to-prepare patients: Evidence from the literature

Endrit Shahini et al.

Summary: Adequate bowel cleansing is crucial for high-quality colonoscopy, but suboptimal preparation is still common. Guidelines recommend high-volume or low-volume PEG/non-PEG-based split-dose regimens. Additional bowel cleansing can be done the same or next day for patients with insufficient cleansing. A personalized approach to bowel preparation is needed, especially in difficult-to-prepare patients.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Review Microbiology

Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease

Francesco Vito Mandarino et al.

Summary: Gastroparesis (GP) is a gastric disorder characterized by delayed gastric emptying. It causes symptoms such as nausea, post-prandial fullness, and early satiety. The epidemiological burden of GP is difficult to assess due to its overlap with functional dyspepsia.

MICROORGANISMS (2023)

Article Gastroenterology & Hepatology

Effectiveness and safety of 1-L PEG-ASC versus other bowel preparations for colonoscopy: A meta-analysis of nine randomized clinical trials

M. Maida et al.

Summary: This meta-analysis evaluated the effectiveness and safety of 1-L PEG-ASC compared to other bowel preparations for colonoscopy. The results showed that 1-L PEG-ASC had higher cleansing success and right-colon high-quality cleansing rates compared to other preparations, with similar adenoma detection rates. However, the incidence of adverse events was higher with 1-L PEG-ASC, although no serious adverse events or deaths occurred.

DIGESTIVE AND LIVER DISEASE (2023)

Review Microbiology

Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together-A Review

Noemi Salmeri et al.

Summary: Endometriosis and irritable bowel syndrome (IBS) are chronic conditions affecting up to 10% of the global population, with gut dysbiosis playing a significant role in both diseases. Emerging research has shown distinct differences in gut microbiota composition between healthy individuals and those with endometriosis or IBS. Intestinal dysbiosis impacts intestinal permeability, triggers inflammation, and affects the gut-brain axis, highlighting the potential for microbiota-focused therapies.

MICROORGANISMS (2023)

Article Gastroenterology & Hepatology

Quality of endoscopic screening for colorectal cancer in Italy: A national survey

M. Maida et al.

Summary: The quality of endoscopic screening for colorectal cancer (CRC) in Italy is generally high, but there are also significant deficiencies and discrepancies in procedural attitudes between different centers. Urgent action is needed to address these shortcomings, improve the behavior of all screening centers, and enhance outcomes.

DIGESTIVE AND LIVER DISEASE (2022)

Article Gastroenterology & Hepatology

Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases

M. Maida et al.

Summary: The study evaluated the effectiveness and safety of 1 L PEG-ASC solution in IBD patients, showing higher cleansing success in IBD patients compared to controls. Factors associated with cleansing success in IBD patients included younger age, split preparation, absence of diabetes, and chronic constipation. Treatment-emergent adverse events were similar between IBD patients and controls.

DIGESTIVE AND LIVER DISEASE (2021)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Effectiveness of very low-volume preparation for colonoscopy: A prospective, multicenter observational study

Marcello Maida et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Article Pharmacology & Pharmacy

Tenapanor for the treatment of irritable bowel syndrome with constipation

Emanuele Sinagra et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)

Review Immunology

The intestinal microbiota fuelling metabolic inflammation

Herbert Tilg et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Medical Laboratory Technology

The Ever-Changing Landscape of Drug-Induced Injury of the Lower Gastrointestinal Tract

Esmeralda Celia Marginean

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)

Article Gastroenterology & Hepatology

Inflammation in irritable bowel syndrome: Myth or new treatment target?

Emanuele Sinagra et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Cell Biology

Iatrogenic pathology of the intestines

Aoife J. McCarthy et al.

HISTOPATHOLOGY (2015)

Review Gastroenterology & Hepatology

Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome

Emanuele Sinagra et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)

Review Immunology

Enterohemorrhagic E. coli (EHEC) pathogenesis

Y. Nguyen et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)

Review Immunology

Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies

Alline R. Pacheco et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)

Article Gastroenterology & Hepatology

The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome

Kamil Ozdil et al.

BMC GASTROENTEROLOGY (2011)

Review Microbiology

Verocytotoxin-producing Escherichia coli (VTEC)

Mohamed A. Karmali et al.

VETERINARY MICROBIOLOGY (2010)

Article Gastroenterology & Hepatology

Endoscopic Findings and Clinicopathologic Characteristics of Ischemic Colitis: A Report of 85 Cases

Xiaoping Zou et al.

DIGESTIVE DISEASES AND SCIENCES (2009)

Review Gastroenterology & Hepatology

Present status and strategy of NSAIDs-induced small bowel injury

Kazuhide Higuchi et al.

JOURNAL OF GASTROENTEROLOGY (2009)

Letter Gastroenterology & Hepatology

What's the Best Way to Differentiate Infectious Colitis (Acute Self-Limited Colitis) from IBD?

Christina M. Surawicz

INFLAMMATORY BOWEL DISEASES (2008)

Article Medicine, General & Internal

Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis

Christoph Hoegenauer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Gastroenterology & Hepatology

Colonic toxicity of administered drugs and chemicals

MS Cappell

AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)

Article Pathology

The clinical significance of focal active colitis in pediatric patients

W Xin et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)

Review Infectious Diseases

Epidemiology and spectrum of disease of Escherichia coli O157

TJ Ochoa et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2003)